In the last years, the application of "nanotechnology “to the field of “medicine” surely represented the most innovative strategy to cope with diseases and it coule be named as nanomedicine applied to difficult-to-treat diseases. As known, in this field of research, the most important goal to be reached is an increase in selectivity and specificity of drug action. Several results with stimulating findings in preclinical or clinical phases have been reached by using nanocarriers, delivering agents to targeted pathologies, and among them, it is known that neuro-pathologies represent a stimulating issue. In fact, the pharmaceutical treatment of Central Nervous System (CNS) disorders is the second largest area of therapy, following cardiovascular diseases. Nowadays, non-invasive drug delivery systems for CNS are actively studied. The nano-technological approach consist of the use of nanosystems (colloidal carriers) which could be polymer-based (nanoparticles, Np) or solid lipid material made (solid lipid nanoparticles, SLNp) and lipid-based (liposomes, LP). In fact, the development of these new delivery systems started with the discovery that properly surface-engineered colloidal vectors, with a diameter around 200 nm, were shown to be able to cross the BBB without apparent damage, and to deliver drugs or genetic materials into the brain. During this talk, an overview will be presented considering the most recent literature results of nanomedicine applied to brain diseases, carried out with all the most popular kinds of nanoparticulate systems, focusing in particular on peptide-decorated nanosystems able to target the CNS.
Nanotechnology for the CNS drug delivery and targeting / Tosi, Giovanni; Ruozi, Barbara; Bondioli, Lucia; Badiali, Luca; Vandelli, Maria Angela; Forni, Flavio. - STAMPA. - 1(2010), pp. 6-6. ((Intervento presentato al convegno World Congress of Neurotechnology tenutosi a Rome nel 12-14 October 2010.
|Data di pubblicazione:||2010|
|Titolo:||Nanotechnology for the CNS drug delivery and targeting|
|Autore/i:||Tosi, Giovanni; Ruozi, Barbara; Bondioli, Lucia; Badiali, Luca; Vandelli, Maria Angela; Forni, Flavio|
|Nome del convegno:||World Congress of Neurotechnology|
|Luogo del convegno:||Rome|
|Data del convegno:||12-14 October 2010|
|Citazione:||Nanotechnology for the CNS drug delivery and targeting / Tosi, Giovanni; Ruozi, Barbara; Bondioli, Lucia; Badiali, Luca; Vandelli, Maria Angela; Forni, Flavio. - STAMPA. - 1(2010), pp. 6-6. ((Intervento presentato al convegno World Congress of Neurotechnology tenutosi a Rome nel 12-14 October 2010.|
|Tipologia||Relazione in Atti di Convegno|
File in questo prodotto:
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris